PLAY PODCASTS
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Italy
Episode 37

Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Italy

Listen to Guiseppe Procopio, MD, and Cora N. Sternberg, MD, FACP, discuss in Italian the latest clinical data on immune checkpoint inhibitors for advanced urothelial cancer.

Decera Clinical Education Oncology Podcast · Guiseppe Procopio MD, Cora N. Sternberg MD FACP

February 4, 202125m 33s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Guiseppe Procopio, MD, and Cora N. Sternberg, MD, FACP, discuss in Italian the latest immuno-oncology developments in the treatment of urothelial cancer.  

Presenters:

Guiseppe Procopio, MD  
Head of the Medical Oncology Genitourinary, Istituto Nazionale Tumori
Medical Oncology
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy

Cora N. Sternberg, MD, FACP
Professor of Medicine
Department of Hematology/Oncology
Weill Cornell Medicine
New York, New York, USA

Content based on an online IME program supported by educational grants from EMD Serono, Inc and Pfizer.

Link to full program, including associated downloadable slidesets and on-demand Webcast: http://bit.ly/3kJC5SL


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

avelumabaifabladder cancerpembrolizumabgemcitabinepd-1cisplatin ineligiblefirst-line therapyguiseppe procopiosacituzumab govitecanurothelial cancerctla-4imvigor 130carboplatinenfortumab vedotinsecond-line therapycora sternberggenitourinary canceratezolizumabcisplatinpd-l1